Mid-cap pharma stock Akum Drugs rebounds 35% from April lows. Should you buy or sell the stock?
Mid-cap pharma stock Akum Drugs has been rebounding well, rising almost 35% from April lows amid renewed strength in the domestic stock market. Akums Drugs and Pharmaceuticals’ share price has seen sharp gains of almost 35% from closing lows of around ₹421 seen on the BSE on April 7, 2025, to ₹568 levels now. The…